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Summary. The role of the pineal as an oncostatic gland 
has been studied in animal models of tumorigenesis, 
especially on those concerning the mammary gland. The 
general conclusion is that experimental manipulations 
activating pineal gland, or the administration of 
melatonin, reduce the incidence and growth rate of 
chemically-induced murine mammary tumors, while 
pinealectomy or situations which implicate a reduction 
of melatonin production usually stimulate mammary 
carcinogenesis. The direct actions of melatonin on 
mammary tumors have been suggested because of its 
ability to inhibit, at physiological doses (InM), the in 
vitro proliferation of MCF-7 human breast cancer cells. 
In this article we review the outstanding findings related 
to melatonin actions on mammary which, taken together, 
support a possible usefulnes of this indoleamine in the 
prevention and treatment of mammary gland 
malignancy. 
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Introduction 
The role of the pineal gland, mediated by its 
hormonal secretion melatonin, in the growth and spread 
of different kinds of tumors has been the subject of 
numerous studies from the first quarter of this century 
(Reiter, 1988; Bartsch et al., 1992; Blask, 1993). Among 
the neoplastic processes influenced by melatonin, those 
affecting the mammary gland have been the most 
extensively studied. More than twenty years ago, Cohen 
et al. (1978) were the first to suggest that a decrease in 
pineal activity (and consequently a low melatonin 
production) would contribute to the ethiology of breast 
cancer by leading to a state of relative hyperestrogenism. 
From this time, most studies on rnelatonin antitumoral 
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effects have been based on the inhibitory actions of 
melatonin on the neuroendocrine-reproductive axis, 
decreasing the circulating levels of gonadal estrogens, 
which are considered to play a major role in promoting 
the proliferation of neoplastic mammary epithelium 
(Nandi et al., 1995; Russo and Russo, 1998). The aim of 
this article is to review some of the experimental 
evidence which gives support to the hypothesis that 
melatonin could serve as an oncostatic drug of possible 
utilization in the prevention and treatment of breast 
cancer, the most frequent ontological malignancy 
diagnosed in women in the Western world. 
Melatonin as a modifier of the susceptibility of the 
mammary gland to neoplasia 
The ability of the pineal gland to influence 
mammary gland susceptibility to the action of chemical 
carcinogens, through the secretion of melatonin, has 
been studied with different experimental approaches, 
mostly based on the induction of changes in the pineal 
gland function and evaluation of its effects on the 
carcinogenic process. In our laboratory, we compared 
the mammary carcinogenesis induced by a chemical 
carcinogen (7,12 dimethylbenz[a]anthracene; DMBA) in 
rats in which pineal actions (induced by light 
deprivation) had been previously either enhanced or 
suppressed. The treatments to increase the sensitivity to 
the pineal activation consisted in rendering the animals 
anosmic (Reiter and Klein, 1969; Sorrentino et al., 
1971b; Reiter, 1980; Sbnchez-Barcel6 et al., 1985), or 
reducing their daily food intake (underfeeding) 
(Sorrentino et al., 1971a; Reiter, 1980) or exposing them 
to low environmental temperature (10 T) (Sinchez- 
Barcel6 et al., 1986). Suppression of pineal actions 
(SPA) was obtained by pinealectomy. DMBA was given 
to the animals 1 month after their being treated to either 
enhance or suppress pineal actions. We conclude that in 
animals in which pineal actions had been enhanced, the 
tumoral latency significantly enlarged and the tumoral 
incidence decreased, these effects being prevented by 
pinealectomy (Fig. 1). Furthermore, in animals with 
enhanced pineal actions, most mammary tumors 










